Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
BACKGROUND: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended for malaria prevention in HIV-negative pregnant women, but it is contraindicated in HIV-infected women taking daily cotrimoxazole prophylaxis (CTXp) because of potential added risk of...
Main Authors: | Raquel González, Meghna Desai, Eusebio Macete, Peter Ouma, Mwaka A Kakolwa, Salim Abdulla, John J Aponte, Helder Bulo, Abdunoor M Kabanywanyi, Abraham Katana, Sonia Maculuve, Alfredo Mayor, Arsenio Nhacolo, Kephas Otieno, Golbahar Pahlavan, María Rupérez, Esperança Sevene, Laurence Slutsker, Anifa Vala, John Williamsom, Clara Menéndez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-09-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC4172537?pdf=render |
Similar Items
-
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.
by: Raquel González, et al.
Published: (2014-09-01) -
Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.
by: Raquel González, et al.
Published: (2017-01-01) -
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
by: María Rupérez, et al.
Published: (2016-02-01) -
Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
by: Clara Pons-Duran, et al.
Published: (2022-09-01) -
Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial.
by: Samantha Rada, et al.
Published: (2018-01-01)